About Us | Contact

Dr. Eric J. Avery Investigator

Medical Oncology The Nebraska Medical Center NPI1093934598
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$19,614.64
from 62 payments in the last 6 years

Total Cash or Cash Equivalent

$16,424.27
from 16 payments in the last 6 years

Total In-kind Items & Services

$3,190.37
from 46 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
06/01/2021 General (Non-Research) In-kind items and services Education $11.92 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 845870623
11/10/2021 General (Non-Research) In-kind items and services Food and Beverage $23.65 Details
Payment from GENZYME CORPORATION
Payment Record ID 843425855
06/25/2021 General (Non-Research) In-kind items and services Education $11.50 Details
Payment from Epizyme, Inc.,
Payment Record ID 832337915
10/11/2021 General (Non-Research) In-kind items and services Food and Beverage $16.55 Details
Payment from Seagen Inc.
Payment Record ID 832170597
11/16/2020 General (Non-Research) In-kind items and services Education $12.45 Details
Payment from Karyopharm Therapeutics Inc.
Payment Record ID 751733109
07/13/2020 General (Non-Research) Cash or cash equivalent Education $99.00 Details
Payment from Incyte Corporation
Payment Record ID 745810041
01/15/2020 General (Non-Research) Cash or cash equivalent Food and Beverage $11.81 Details
Payment from Incyte Corporation
Payment Record ID 745809917
06/29/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $1665.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 736108041
10/22/2020 General (Non-Research) In-kind items and services Food and Beverage $21.62 Details
Payment from Seagen Inc.
Payment Record ID 732461609
04/20/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $670.00 Details
Payment from McKesson Specialty Care Distribution, LLC
Payment Record ID 730064921
09/04/2020 General (Non-Research) In-kind items and services Food and Beverage $12.30 Details
Payment from AbbVie Inc.
Payment Record ID 721683553
07/31/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $987.50 Details
Payment from Janssen Biotech, Inc.
Payment Record ID 719132473
01/08/2020 General (Non-Research) In-kind items and services Food and Beverage $14.45 Details
Payment from Janssen Biotech, Inc.
Payment Record ID 719132471
07/19/2019 General (Non-Research) In-kind items and services Food and Beverage $11.32 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695862769
07/19/2019 General (Non-Research) In-kind items and services Food and Beverage $11.32 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 695766015
05/22/2019 General (Non-Research) In-kind items and services Food and Beverage $15.58 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 685560879
02/07/2019 General (Non-Research) In-kind items and services Food and Beverage $11.46 Details
Payment from Genentech USA, Inc.
Payment Record ID 681271153
10/23/2019 General (Non-Research) In-kind items and services Food and Beverage $11.03 Details
Payment from Foundation Medicine, Inc.
Payment Record ID 675547297
07/31/2019 General (Non-Research) In-kind items and services Food and Beverage $11.99 Details
Payment from Foundation Medicine, Inc.
Payment Record ID 675547295
01/22/2019 Research Cash or cash equivalent $466.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED PHASE 3 STUDY OF NONSTEROIDAL AROMATASE INHIBITORS -ANASTROZOLE OR LETROZOLE- PLUS LY2835219 A CDK4-6 INHIBITOR OR PLACEBO IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE HER2-NEGATIVE LOCOREGIONALLY RECURRENT
Clinical Trials Gov ID NCT02246621
Payment Record ID 654282295
03/26/2019 Research In-kind items and services $70.35 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER
Clinical Trials Gov ID NCT03155997
Payment Record ID 654282095
02/26/2019 Research Cash or cash equivalent $2568.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER
Clinical Trials Gov ID NCT03155997
Payment Record ID 654282007
04/25/2019 General (Non-Research) Cash or cash equivalent Food and Beverage $8.15 Details
Payment from Veran Medical Technologies, Inc.
Payment Record ID 651865205
03/12/2019 General (Non-Research) Cash or cash equivalent Food and Beverage $10.95 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 651369259
02/01/2019 General (Non-Research) In-kind items and services Food and Beverage $13.32 Details
Payment from AbbVie, Inc.
Payment Record ID 647863577
04/03/2018 General (Non-Research) In-kind items and services Food and Beverage $12.48 Details
Payment from Seattle Genetics, Inc.
Payment Record ID 607609841
04/03/2018 General (Non-Research) In-kind items and services Food and Beverage $12.48 Details
Payment from Seattle Genetics, Inc.
Payment Record ID 607589417
09/19/2018 General (Non-Research) In-kind items and services Food and Beverage $10.71 Details
Payment from Genentech USA, Inc.
Payment Record ID 602437090
09/07/2018 General (Non-Research) In-kind items and services Food and Beverage $10.94 Details
Payment from Genentech USA, Inc.
Payment Record ID 602437079
11/26/2018 Research In-kind items and services $663.82 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER
Clinical Trials Gov ID NCT03155997
Payment Record ID 585602093
02/20/2018 Research Cash or cash equivalent $1398.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED PHASE 3 STUDY OF NONSTEROIDAL AROMATASE INHIBITORS -ANASTROZOLE OR LETROZOLE- PLUS LY2835219 A CDK4-6 INHIBITOR OR PLACEBO IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE HER2-NEGATIVE LOCOREGIONALLY RECURRENT
Clinical Trials Gov ID NCT02246621
Payment Record ID 585602091
02/06/2018 Research Cash or cash equivalent $3736.00 Details
Payment from Eli Lilly and Company
Paymment Research Study NEOMONARCH - A PHASE 2 NEOADJUVANT TRIAL COMPARING THE BIOLOGICAL EFFECTS OF 2 WEEKS OF ABEMACICLIB -LY2835219- IN COMBINATION WITH ANASTROZOLE TO THOSE OF ABEMACICLIB MONOTHERAPY AND ANASTROZOLE MONOTHERAPY AND EVALUATING THE CLINICAL ACTIVITY AND SAFETY OF A SUBSEQUENT 14 WEEKS OF THERAPY WITH ABEMACICLIB IN COMBINATION WITH ANASTROZOLE IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE, HER2 NEGATIVE BREAST CANCER
Clinical Trials Gov ID NCT02441946
Payment Record ID 585602089
10/25/2018 Research In-kind items and services $190.25 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED PHASE 2 TRIAL OF AM0010 IN COMBINATION WITH PEMBROLIZUMAB VS. PEMBROLIZUMAB ALONE AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER WHOSE TUMORS HAVE HIGH PD-L1 EXPRESSION
Payment Record ID 585602087
12/17/2018 General (Non-Research) Cash or cash equivalent Food and Beverage $12.64 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 572142147
12/18/2018 General (Non-Research) In-kind items and services Food and Beverage $12.67 Details
Payment from AbbVie, Inc.
Payment Record ID 571624263
10/17/2018 General (Non-Research) In-kind items and services Food and Beverage $11.39 Details
Payment from AbbVie, Inc.
Payment Record ID 571325663
01/25/2018 General (Non-Research) In-kind items and services Travel and Lodging $12.50 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 562281139
07/18/2018 General (Non-Research) In-kind items and services Food and Beverage $23.33 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 562149125
01/25/2018 General (Non-Research) In-kind items and services Travel and Lodging $556.61 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 561924117
07/18/2018 General (Non-Research) In-kind items and services Food and Beverage $12.75 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 561834106
07/18/2018 General (Non-Research) In-kind items and services Food and Beverage $57.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 561820893
01/25/2018 General (Non-Research) In-kind items and services Food and Beverage $22.29 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 561652232
07/18/2018 General (Non-Research) In-kind items and services Food and Beverage $5.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 561531429
08/14/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $2350.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 561391969
01/25/2018 General (Non-Research) In-kind items and services Travel and Lodging $258.20 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 561319594
07/18/2018 General (Non-Research) In-kind items and services Travel and Lodging $696.41 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 561113893
07/18/2018 General (Non-Research) In-kind items and services Food and Beverage $15.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 560527039
07/18/2018 General (Non-Research) In-kind items and services Travel and Lodging $20.40 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 560502411
02/01/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $2350.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 560385955
07/18/2018 General (Non-Research) In-kind items and services Food and Beverage $15.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 559842773
01/25/2018 General (Non-Research) In-kind items and services Food and Beverage $107.30 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 559791939
01/10/2017 General (Non-Research) In-kind items and services Food and Beverage $15.57 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503595299
08/30/2017 General (Non-Research) Cash or cash equivalent Food and Beverage $78.34 Details
Payment from McKesson Specialty Care Distribution Corp.
Payment Record ID 488550922
02/02/2017 General (Non-Research) In-kind items and services Food and Beverage $11.35 Details
Payment from Genentech USA, Inc.
Payment Record ID 488198343
07/19/2017 General (Non-Research) In-kind items and services Food and Beverage $13.55 Details
Payment from AbbVie, Inc.
Payment Record ID 472143974
08/21/2017 General (Non-Research) In-kind items and services Food and Beverage $19.86 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 446163539
02/02/2016 General (Non-Research) In-kind items and services Food and Beverage $13.40 Details
Payment from TOLMAR Pharmaceuticals, Inc.
Payment Record ID 413233238
09/06/2016 General (Non-Research) In-kind items and services Food and Beverage $14.05 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 405861744
10/20/2016 General (Non-Research) Cash or cash equivalent Education $12.88 Details
Payment from E.R. Squibb & Sons, L.L.C.
Payment Record ID 398485586
07/20/2016 General (Non-Research) In-kind items and services Food and Beverage $10.28 Details
Payment from Boehringer Ingelheim Pharmaceuticals, Inc.
Payment Record ID 381491502
05/18/2016 General (Non-Research) In-kind items and services Food and Beverage $12.37 Details
Payment from Medivation Inc.
Payment Record ID 381420878
07/26/2016 Research In-kind items and services $72.60 Details
Payment from Eli Lilly and Company
Paymment Research Study A PROSPECTIVE RANDOMIZED OPEN-LABEL COMPARISON OF A LONG-ACTING BASAL INSULIN ANALOG LY2963016 TO LANTUS IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS - THE ELEMENT 5 STUDY
Clinical Trials Gov ID NCT02302716
Payment Record ID 372519478
;